Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Antigonadal effects of prolactin in female Anolis carolinensis.

Hensgen HT, Rainey JM, Gist DH.

Gen Comp Endocrinol. 1980 May;41(1):22-30. No abstract available.

PMID:
6771184

Supplemental Content

Loading ...
Support Center